%0 Journal Article
%T Duration of triple antithrombotic therapy and outcomes among patients undergoing percutaneous coronary intervention
%A Glenda Delgado
%A Rahman Shah
%A Shannon W. Finks
%J SCIE-indexed Journal
%D 2017
%X In the July 2016 issue of JACC: Cardiovascular Interventions, Koskinas et al. used observational registry data to compare the safety and efficacy outcomes of triple antithrombotic therapy (TAT) prescribed for one month versus longer-duration TAT in patients undergoing percutaneous coronary intervention (PCI) with a clear indication for oral anticoagulation (OAC) therapy (1)
%U http://cdt.amegroups.com/article/view/12777/15377